Exclusive

Publication

Byline

Location

US Patent Issued to Altos Labs on June 23 for "ATF6 modulators and uses thereof" (Chilean, Indian, American Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,478, issued on June 23, was assigned to Altos Labs Inc. (Redwood City, Calif.). "ATF6 modulators and uses thereof" was invented by Brahmam ... Read More


US Patent Issued to Foghorn Therapeutics on June 23 for "Compounds and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,479, issued on June 23, was assigned to Foghorn Therapeutics Inc. (Cambridge, Mass.). "Compounds and uses thereof" was invented by Matthew ... Read More


US Patent Issued to SYNGENTA CROP PROTECTION on June 23 for "Microbiocidal derivatives" (Swiss Inventor)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,480, issued on June 23, was assigned to SYNGENTA CROP PROTECTION AG (Basel, Switzerland). "Microbiocidal derivatives" was invented by Andre... Read More


US Patent Issued to Repare Therapeutics on June 23 for "Substituted 2-morpholinopyridine derivatives as ATR kinase inhibitors" (Canadian Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,481, issued on June 23, was assigned to Repare Therapeutics Inc. (St-Laurent, Canada). "Substituted 2-morpholinopyridine derivatives as ATR... Read More


US Patent Issued to The Johns Hopkins University, Lieber Institute on June 23 for "Compounds which inhibit RNA polymerase" (American, Finnish Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,482, issued on June 23, was assigned to The Johns Hopkins University (Baltimore) and Lieber Institute Inc. (Baltimore). "Compounds which in... Read More


US Patent Issued to Eli Lilly and Co. on June 23 for "Cocrystalline forms of FGFR3 inhibitors" (Indiana Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,483, issued on June 23, was assigned to Eli Lilly and Co. (Indianapolis). "Cocrystalline forms of FGFR3 inhibitors" was invented by David A... Read More


US Patent Issued to Shenzhen TargetRx on June 23 for "Substituted piperidines as bruton's tyrosine kinase inhibitors" (Chinese Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,484, issued on June 23, was assigned to Shenzhen TargetRx Inc. (Shenzhen, China). "Substituted piperidines as bruton's tyrosine kinase inhi... Read More


US Patent Issued to AUGUSTA UNIVERSITY RESEARCH INSTITUTE on June 23 for "Substituted pyrazolo[4,3-Dpyrimidines as gut-targeted phosphodiesterase inhibitors" (Georgia Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,485, issued on June 23, was assigned to AUGUSTA UNIVERSITY RESEARCH INSTITUTE INC. (Augusta, Ga.). "Substituted pyrazolo[4,3-Dpyrimidines a... Read More


US Patent Issued to ASSIA CHEMICAL INDUSTRIES on June 23 for "Solid state forms of AT-001 and process for preparation thereof" (Indian Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,486, issued on June 23, was assigned to ASSIA CHEMICAL INDUSTRIES LTD. (Tel Aviv, Israel). "Solid state forms of AT-001 and process for pre... Read More


US Patent Issued to SANOFI on June 23 for "Imidazo[1,2-b[1,2,4triazol derivatives for use in therapy" (French Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,487, issued on June 23, was assigned to SANOFI (Paris). "Imidazo[1,2-b[1,2,4triazol derivatives for use in therapy" was invented by Antonio... Read More